.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Queensland Health
Cerilliant
Chubb
Moodys
UBS
Deloitte
Mallinckrodt
QuintilesIMS
Fuji

Generated: January 20, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Japan Patent: 2000-175966

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Eisai IncFYCOMPAperampanelSUSPENSION;ORAL208277-001Apr 29, 2016RXYesYes➤ Subscribe➤ SubscribeYY
Eisai IncFYCOMPAperampanelSUSPENSION;ORAL208277-001Apr 29, 2016RXYesYes➤ Subscribe➤ SubscribeYYTREATMENT OF EPILEPSY
Eisai IncFYCOMPAperampanelTABLET;ORAL202834-001Oct 22, 2012RXYesNo➤ Subscribe➤ SubscribeYY
Eisai IncFYCOMPAperampanelTABLET;ORAL202834-001Oct 22, 2012RXYesNo➤ Subscribe➤ SubscribeYYTREATMENT OF EPILEPSY
Eisai IncFYCOMPAperampanelTABLET;ORAL202834-002Oct 22, 2012RXYesNo➤ Subscribe➤ SubscribeYY
Eisai IncFYCOMPAperampanelTABLET;ORAL202834-002Oct 22, 2012RXYesNo➤ Subscribe➤ SubscribeYYTREATMENT OF EPILEPSY
Eisai IncFYCOMPAperampanelTABLET;ORAL202834-003Oct 22, 2012RXYesNo➤ Subscribe➤ SubscribeYY
Eisai IncFYCOMPAperampanelTABLET;ORAL202834-003Oct 22, 2012RXYesNo➤ Subscribe➤ SubscribeYYTREATMENT OF EPILEPSY
Eisai IncFYCOMPAperampanelTABLET;ORAL202834-004Oct 22, 2012RXYesNo➤ Subscribe➤ SubscribeYY
Eisai IncFYCOMPAperampanelTABLET;ORAL202834-004Oct 22, 2012RXYesNo➤ Subscribe➤ SubscribeYYTREATMENT OF EPILEPSY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist